UTHSC, Regional One to perform clinical trials in Memphis for possible COVID-19 drug
The University of Tennessee Health Science Center and Regional One Health are partnering on a clinical trial program in Memphis to evaluate a drug for COVID-19 treatment. The Memphis medical college and hospital announced Thursday they will provide late-stage trials for Regeneron’s REGN-COV2, an antibody cocktail the company is investigating for possible treatment and prevention… Read More